CRISPR

The loss of ΙκΒε inhibitor accelerates disease development in Chronic Lymphocytic Leukemia

Chronic lymphocytic leukemia (CLL) is an indolent B cell malignancy in which B lymphocytes accumulate in peripheral blood (PB), bone …

Chiara Lenzi, Jessica Bordini, Athanasios Pseftogkas, Alessia Morabito, George Tsiolas, Fotis E. Psomopoulos, Alessandro Campanella, Michaela Frenquelli, Paolo Ghia